Physician profile
Ryan Nolan
NPI 1265832950
$8,995.74
in general payments reported to CMS, 2019-2025
14 companies · $634 in 2025
The $634 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $2,929 · 2021: $3,184 · 2022: $74.83 · 2023: $1,799 · 2024: $237 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,665 · Food and Beverage: $989 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,665.28 |
| Food and Beverage | $988.73 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,347.62 | 2020-2025 | Da Vinci Surgical System |
| Covidien Lp | $606.76 | 2020 | |
| Smith+Nephew, INC. | $264.01 | 2023-2025 | Grafix, Stravix, Collagenase Santyl |
| Janssen Biotech, INC. | $169.77 | 2025 | Tremfya |
| Davol INC. | $157.34 | 2019-2021 | |
| Glaukos Corporation | $136.13 | 2023 | |
| Acell, INC. | $89.02 | 2020 | |
| Abbott Laboratories | $48.69 | 2022 | |
| Medtronic, INC. | $47.71 | 2021 | |
| Abbvie INC. | $44.92 | 2023-2024 | |
| Baxter Healthcare | $26.14 | 2022 | |
| Braintree Laboratories, INC. | $21.61 | 2025 | Sutab, Suflave |
| Intercept Pharmaceuticals, INC. | $18.58 | 2025 | |
| Integra Lifesciences Corporation | $17.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Nolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.